Axis Capital Holdings Ltd. (AXS) Financials Nov 14, 2014,

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Axis Capital Holdings Ltd. (AXS) Financials Nov 14, 2014, 4:28 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Axis Capital Holdings Ltd.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 3.15B 3.57B 3.82B 3.95B 4.2B
Premiums Earned 2.79B 2.95B 3.31B 3.42B 3.71B
Total Investment Income 464.48M 406.89M 362.43M 380.96M 409.31M
Realized Gains (Losses) 25.85M 213.03M 137.3M 151.7M 77.2M
Other Operating Income (129.68M) 2.07M 2.4M 2.68M 4.42M
Losses, Claims & Reserves 1.42B 1.68B 2.68B 2.1B 2.13B
Losses, Benefits & Adjustments 1.42B 1.68B 2.68B 2.1B 2.13B
2009 2010 2011 2012 2013 5-year trend
Selling, General & Admin. Expenses & Other 790.65M 938.6M 1.05B 1.19B 1.23B
Selling, General & Admin. Expenses 790.65M 938.6M 1.03B 1.17B 1.22B
Other Selling, General & Admin. Expense 370.16M 449.89M 442.25M 547.16M 552.12M
Underwriting & Commissions 420.5M 488.71M 587.47M 627.65M 664.19M
Other Operating Expense 0 0 16.91M 13.82M 15.54M
Operating Income Before Interest Expense 937.89M 953.68M 95.42M 666.14M 831.95M
Interest Expense, Net of Interest Capitalized 32.03M 55.88M 62.6M 61.86M 61.98M
Interest Expense (excl. Interest Capitalized) 32.03M 55.88M 62.6M 61.86M 61.98M
Interest Capitalized 0 0 0 0 0
Operating Income After Interest Expense 905.86M 897.8M 32.82M 604.27M 769.97M
Non-Operating Income (Expense) (28.56M) 15.54M 44.58M (29.51M) (26.14M)
Miscellaneous Non Operating Expense (28.56M) 15.54M 44.58M (29.51M) (26.14M)
Equity in Affiliates (Pretax) 0 0 0 0 0
Unusual Expense 337.44M 17.93M 15.86M 24.23M 9.36M
Pretax Income 539.86M 895.4M 61.54M 550.53M 734.47M
Income Taxes 41.98M 38.68M 15.23M 3.29M 7M
Income Tax - Current - Domestic 32.59M 26.63M 5.06M 4.93M 12.47M
Income Tax - Current - Foreign 7.02M 12.29M 9.79M 8.39M 9.04M
Income Tax - Deferred - Domestic 2.25M 121,000 1.38M (10.75M) (13.98M)
Income Tax - Deferred - Foreign 113,000 (367,000) (996,000) 713,000 (527,000)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - 0 (14.01M) (3.08M)
Consolidated Net Income 497.89M 856.72M 46.31M 533.23M 724.38M
Minority Interest Expense 0 0 0 0 -
Net Income 497.89M 856.72M 46.31M 533.23M 724.38M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 497.89M 856.72M 46.31M 533.23M 724.38M
Preferred Dividends 36.88M 36.88M 36.88M 38.23M 40.47M
Net Income Available to Common 461.01M 819.85M 9.43M 495M 683.91M
EPS (Basic) 3.36 6.74 0.08 4.05 6.02
Basic Shares Outstanding 137.28M 121.73M 122.5M 122.15M 113.64M
EPS (Diluted) 3.07 6.02 0.07 4.00 5.93
Diluted Shares Outstanding 150.37M 136.2M 128.12M 123.65M 115.33M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 5

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 6

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 9

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Huggies and Walgreens Uniting to Tackle Diaper Need

Updated Category News Views 300

Partnering to Tackle Diaper Needs Huggies and Walgreens are thrilled to kick off a meaningful initiative designed to support families dealing with diaper need. For each pack of Huggies Diapers bought at Walgreens, either in stores or online, Huggies will donate a day's worth of diapers to the National Diaper Bank Network, aiming to contribute as many as one million...

Continue Reading
Surging Growth of Fatty Methyl Ester Sulfonate Market By 2033

Updated Category News Views 144

Exploring the Future of the Fatty Methyl Ester Sulfonate Market The dynamic world of the fatty methyl ester sulfonate (FMES) market is entering an exciting phase of growth. Beginning at an estimated value of US$ 805.9 million in 2024, the forecast projects the market to surge to US$ 2,095.1 million by 2033. This impressive leap represents an annual growth rate of 11.20%,...

Continue Reading
Biden Administration Approves Perpetua's Mining Project

Updated Category News Views 151

Biden Administration Approves Perpetua's Mining Project In a significant move for resource management and economic development, the Biden administration has granted the final mining permit for Perpetua Resources' antimony and gold mine located in Idaho. This decision comes in response to concerns regarding China's substantial control over the global market for antimony, a...

Continue Reading
Neurocrine Biosciences Set to Share Q2 2025 Financial Insights

Updated Category News Views 130

Neurocrine Biosciences Announces Upcoming Financial Conference Call Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a leader in the field of neuroscience, is excited to inform stakeholders about its scheduled conference call and webcast. The event is set for the afternoon of July 30, where financial results for the second quarter of 2025 will be shared. This moment allows...

Continue Reading
Societe Generale Updates on Universal Registration Document

Updated Category News Views 127

Introducing the Second Amendment Societe Generale has exciting news regarding the second amendment to its 2025 Universal Registration Document. This essential document plays a crucial role in ensuring transparency and compliance with regulatory frameworks. The amendment was officially filed with the French Financial Markets Authority (AMF), ensuring that all stakeholders...

Continue Reading